Jianxin Ma Selected Research

Jianxin Ma Research Topics

Disease

11	Neoplasms (Cancer) 02/2024 - 09/2011
9	Hypoxia (Hypoxemia) 03/2015 - 09/2011
6	Esophageal Squamous Cell Carcinoma 03/2015 - 11/2013
4	Inflammation (Inflammations) 01/2024 - 01/2017
3	COVID-19 01/2023 - 01/2021
3	Carcinoma (Carcinomatosis) 06/2014 - 09/2011
2	Infections 04/2024 - 08/2011
2	Polyploidy 01/2022 - 01/2010
2	Esophageal Neoplasms (Esophageal Cancer) 10/2014 - 03/2014
1	Neuroinflammatory Diseases 10/2023
1	Neuralgia (Stump Neuralgia) 10/2023
1	Ascites 09/2023
1	Body Weight (Weight, Body) 09/2023
1	Hepatocellular Carcinoma (Hepatoma) 09/2023
1	Sepsis (Septicemia) 01/2023
1	Heart Failure 01/2023
1	Ischemia 01/2022
1	Atrophy 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Enteritis 01/2022
1	Genetic Translocation (Chromosomal Translocation) 11/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 10/2021
1	Chronic Hepatitis B 01/2017
1	Fibrosis (Cirrhosis) 01/2017
1	Necrosis 01/2017
1	Hepatitis B 10/2015
1	Genomic Instability 03/2015
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2015
1	Squamous Cell Carcinoma of Head and Neck 10/2014
1	Prostatic Neoplasms (Prostate Cancer) 05/2014

Drug/Important Bio-Agent (IBA)

8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2023 - 09/2011
5	Proteins (Proteins, Gene)FDA Link 09/2023 - 01/2010
3	CytokinesIBA 01/2024 - 01/2022
3	DNA (Deoxyribonucleic Acid)IBA 09/2023 - 10/2014
3	BerberineIBA 05/2014 - 11/2013
2	Biomarkers (Surrogate Marker)IBA 01/2024 - 10/2021
2	Interleukin-6 (Interleukin 6)IBA 09/2023 - 01/2017
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2022 - 11/2021
1	Neutralizing AntibodiesIBA 04/2024
1	NLR ProteinsIBA 01/2024
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2024
1	InterleukinsIBA 01/2024
1	p38 Mitogen-Activated Protein KinasesIBA 10/2023
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 10/2023
1	GPR39-C3IBA 10/2023
1	Membrane Proteins (Integral Membrane Proteins)IBA 10/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2023
1	Class A Scavenger ReceptorsIBA 09/2023
1	Oxidants (Oxidizing Agents)IBA 09/2023
1	OzoneIBA 09/2023
1	EnzymesIBA 09/2023
1	MetalloproteinsIBA 09/2023
1	Interferon-gamma (Interferon, gamma)IBA 09/2023
1	ImmunosorbentsIBA 09/2023
1	AlbuminsIBA 01/2023
1	AerosolsIBA 01/2023
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2023
1	Monoterpenes (Monoterpenoids)IBA 01/2022
1	pinaneIBA 01/2022
1	GlycosidesIBA 01/2022
1	peoniflorinIBA 01/2022
1	1-Propanol (Propanol)IBA 10/2021
1	N 30IBA 10/2021
1	AcetoneIBA 10/2021
1	Volatile Organic CompoundsIBA 10/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	nutlin 3IBA 01/2018
1	Glutathione (Reduced Glutathione)IBA 01/2017
1	Interleukin-8 (Interleukin 8)IBA 01/2017
1	CollagenIBA 01/2017
1	AcidsIBA 01/2017
1	Alanine Transaminase (SGPT)IBA 01/2017
1	Transaminases (Aminotransferases)IBA 01/2017
1	Bile Acids and Salts (Bile Acids)IBA 01/2017
1	BilirubinIBA 01/2017
1	Laminin (Merosin)IBA 01/2017
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 10/2015
1	MicroRNAs (MicroRNA)IBA 03/2015
1	statticIBA 03/2015
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2015
1	Caspase 3 (Caspase-3)IBA 01/2015
1	Bortezomib (Velcade)FDA Link 01/2015
1	triptolideIBA 10/2014
1	Bee Venoms (Bee Venom)IBA 10/2014
1	Melitten (Melittin)IBA 10/2014
1	NSC 74859IBA 10/2014
1	CaspasesIBA 10/2014
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 10/2014
1	SurvivinIBA 08/2014
1	sepantroniumIBA 08/2014
1	ginsenoside Rg3IBA 06/2014
1	Inhibitor of Apoptosis ProteinsIBA 03/2014
1	LCL161IBA 03/2014
1	Caspase 8 (Caspase-8)IBA 03/2014

Therapy/Procedure

9	Radiotherapy 01/2022 - 11/2013
6	Therapeutics 02/2024 - 10/2014
1	Critical Care (Surgical Intensive Care) 01/2023
1	Length of Stay 01/2023
1	Intraperitoneal Injections 10/2014
1	Chemoradiotherapy 03/2014